PL1814843T3 - (2R)-enancjomer chlorku DOTAP - Google Patents
(2R)-enancjomer chlorku DOTAPInfo
- Publication number
- PL1814843T3 PL1814843T3 PL05802304T PL05802304T PL1814843T3 PL 1814843 T3 PL1814843 T3 PL 1814843T3 PL 05802304 T PL05802304 T PL 05802304T PL 05802304 T PL05802304 T PL 05802304T PL 1814843 T3 PL1814843 T3 PL 1814843T3
- Authority
- PL
- Poland
- Prior art keywords
- dotap
- enantiomer
- chloride
- Prior art date
Links
- KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/08—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to an acyclic carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004057303A DE102004057303A1 (de) | 2004-11-26 | 2004-11-26 | Stabile Kristallmodifikationen von DOTAP Chlorid |
| EP05802304.5A EP1814843B1 (de) | 2004-11-26 | 2005-11-07 | (2r)-enantiomer von dotap-chlorid |
| PCT/EP2005/011874 WO2006056312A1 (de) | 2004-11-26 | 2005-11-07 | Stabile kristallmodifikationen von dotap chlorid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1814843T3 true PL1814843T3 (pl) | 2015-11-30 |
Family
ID=35789283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05802304T PL1814843T3 (pl) | 2004-11-26 | 2005-11-07 | (2R)-enancjomer chlorku DOTAP |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8853283B2 (pl) |
| EP (1) | EP1814843B1 (pl) |
| JP (1) | JP4880612B2 (pl) |
| KR (1) | KR101249370B1 (pl) |
| CN (2) | CN102796016B (pl) |
| AU (1) | AU2005309107B2 (pl) |
| BR (2) | BR122019018186B8 (pl) |
| CA (1) | CA2589218C (pl) |
| DE (1) | DE102004057303A1 (pl) |
| ES (1) | ES2545906T3 (pl) |
| HU (1) | HUE027554T2 (pl) |
| IL (1) | IL183324A (pl) |
| MX (1) | MX2007006128A (pl) |
| NO (1) | NO338885B1 (pl) |
| NZ (2) | NZ582382A (pl) |
| PL (1) | PL1814843T3 (pl) |
| PT (1) | PT1814843E (pl) |
| RU (1) | RU2463291C2 (pl) |
| WO (1) | WO2006056312A1 (pl) |
| ZA (1) | ZA200705169B (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10347710B4 (de) | 2003-10-14 | 2006-03-30 | Johannes-Gutenberg-Universität Mainz | Rekombinante Impfstoffe und deren Verwendung |
| US7303881B2 (en) * | 2004-04-30 | 2007-12-04 | Pds Biotechnology Corporation | Antigen delivery compositions and methods of use |
| DE102005046490A1 (de) | 2005-09-28 | 2007-03-29 | Johannes-Gutenberg-Universität Mainz | Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen |
| US8877206B2 (en) * | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
| AU2009236306B2 (en) * | 2008-04-17 | 2015-04-02 | Pds Biotechnology Corporation | Stimulation of an immune response by enantiomers of cationic lipids |
| CN108285422A (zh) * | 2011-05-20 | 2018-07-17 | 默克专利股份有限公司 | 稳定的dotap氯化物晶体变体 |
| LT2714071T (lt) | 2011-05-24 | 2019-10-10 | Biontech Rna Pharmaceuticals Gmbh | Individualizuotos vakcinos nuo vėžio |
| WO2013039989A1 (en) * | 2011-09-12 | 2013-03-21 | Pds Biotechnology Corporation | Particluate vaccine formulations |
| WO2013143555A1 (en) | 2012-03-26 | 2013-10-03 | Biontech Ag | Rna formulation for immunotherapy |
| US10286064B2 (en) | 2012-06-15 | 2019-05-14 | Pds Biotechnology Corporation | Cationic lipid vaccine compositions and methods of use |
| AU2013317805B2 (en) | 2012-09-21 | 2018-07-26 | Pds Biotechnology Corporation | Improved vaccine compositions and methods of use |
| AU2013351542B2 (en) | 2012-11-28 | 2018-08-09 | BioNTech SE | Individualized vaccines for cancer |
| WO2014180490A1 (en) | 2013-05-10 | 2014-11-13 | Biontech Ag | Predicting immunogenicity of t cell epitopes |
| WO2016045732A1 (en) | 2014-09-25 | 2016-03-31 | Biontech Rna Pharmaceuticals Gmbh | Stable formulations of lipids and liposomes |
| WO2016128060A1 (en) | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
| WO2017059902A1 (en) | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
| US11612652B2 (en) | 2015-11-13 | 2023-03-28 | Pds Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
| CN110662532A (zh) * | 2017-04-03 | 2020-01-07 | 加利福尼亚大学董事会 | 用于跨血脑屏障、透粘膜和经皮药物递送的可变形的纳米级媒介物(dnvs) |
| WO2018224166A1 (en) | 2017-06-09 | 2018-12-13 | Biontech Rna Pharmaceuticals Gmbh | Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy |
| TW201924722A (zh) | 2017-12-05 | 2019-07-01 | 美商Pds生技公司 | 用於刺激第i型干擾素基因之方法及包含陽離子脂質的組合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| DE4013632A1 (de) * | 1990-04-27 | 1991-10-31 | Max Planck Gesellschaft | Liposomen mit positiver ueberschussladung |
| DE19521412A1 (de) * | 1995-06-14 | 1996-12-19 | Boehringer Mannheim Gmbh | Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung |
| NZ332666A (en) * | 1996-05-08 | 2000-05-26 | Nika Health Products Ltd | Cationic virosomes having a positively charged lipid bilayer membrane with an integrated viral fusogenic peptide as genetic transfer systems for use in gene therapy |
| EP0938298B1 (en) * | 1996-09-13 | 2002-12-04 | Lipoxen Technologies Limited | Liposome-based composition |
| US6458382B1 (en) * | 1999-11-12 | 2002-10-01 | Mirus Corporation | Nucleic acid transfer complexes |
| ES2183720B1 (es) | 2001-06-18 | 2004-01-16 | Esteve Labor Dr | Procedimiento para la preparacion de derivados de 1,5-diaril-3-trifluorometil-delta2-pirazolinas racemicas y enantiomericamente puras. |
| ITMI20032185A1 (it) * | 2003-11-12 | 2005-05-13 | Chemi Spa | Processo per la sintesi di lipidi cationici. |
-
2004
- 2004-11-26 DE DE102004057303A patent/DE102004057303A1/de not_active Withdrawn
-
2005
- 2005-11-07 WO PCT/EP2005/011874 patent/WO2006056312A1/de not_active Ceased
- 2005-11-07 BR BR122019018186A patent/BR122019018186B8/pt active IP Right Grant
- 2005-11-07 CA CA2589218A patent/CA2589218C/en not_active Expired - Lifetime
- 2005-11-07 PL PL05802304T patent/PL1814843T3/pl unknown
- 2005-11-07 JP JP2007541742A patent/JP4880612B2/ja not_active Expired - Lifetime
- 2005-11-07 PT PT58023045T patent/PT1814843E/pt unknown
- 2005-11-07 KR KR1020077011691A patent/KR101249370B1/ko not_active Expired - Lifetime
- 2005-11-07 CN CN201210067110.0A patent/CN102796016B/zh not_active Expired - Lifetime
- 2005-11-07 RU RU2007123673/04A patent/RU2463291C2/ru active
- 2005-11-07 AU AU2005309107A patent/AU2005309107B2/en not_active Expired
- 2005-11-07 BR BRPI0518489A patent/BRPI0518489B8/pt active IP Right Grant
- 2005-11-07 EP EP05802304.5A patent/EP1814843B1/de not_active Expired - Lifetime
- 2005-11-07 NZ NZ582382A patent/NZ582382A/en not_active IP Right Cessation
- 2005-11-07 CN CNA2005800405153A patent/CN101065350A/zh active Pending
- 2005-11-07 US US11/720,263 patent/US8853283B2/en not_active Expired - Lifetime
- 2005-11-07 NZ NZ556060A patent/NZ556060A/en not_active IP Right Cessation
- 2005-11-07 MX MX2007006128A patent/MX2007006128A/es active IP Right Grant
- 2005-11-07 HU HUE05802304A patent/HUE027554T2/en unknown
- 2005-11-07 ES ES05802304.5T patent/ES2545906T3/es not_active Expired - Lifetime
-
2007
- 2007-05-20 IL IL183324A patent/IL183324A/en active IP Right Grant
- 2007-06-25 NO NO20073286A patent/NO338885B1/no unknown
- 2007-06-25 ZA ZA200705169A patent/ZA200705169B/xx unknown
-
2014
- 2014-09-02 US US14/474,789 patent/US9457087B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1814843E (pt) | (2r)-enantiómero de cloreto de dotap | |
| PT1778618E (pt) | Síntese de trietilenotetraminas | |
| TWI350744B (en) | Inter-labial pad | |
| EP1809137A4 (en) | ASYMMETRICAL UMBRELLA | |
| EP1806147A4 (en) | USE OF IMMUNOSUPPRESSIVE RECEPTOR | |
| ZA200706093B (en) | Reducing by-catch of seabirds | |
| PL1763520T3 (pl) | Zastosowanie tripodstawionych benzopiranonów | |
| EP1711484A4 (en) | SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES | |
| ZA200701527B (en) | Composition comprising statin | |
| EP1833808A4 (en) | NEW BENZOTHIAZOLSULFONIC ACID AMIDE | |
| AU158365S (en) | Set of fins for surfcraft | |
| GB0418756D0 (en) | Supports | |
| DE602005024518D1 (en) | C10-cyclopentylester-substituierte taxane | |
| GB0403729D0 (en) | Pad | |
| IL178184A0 (en) | Synthesis of pyrrole-2-carbonitriles | |
| GB0519100D0 (en) | Scented pad | |
| GB0410323D0 (en) | Sex aid | |
| IL178683A0 (en) | Methods of diminishing co-abuse potenitial | |
| GB2416051B (en) | Selection of component | |
| GB0411026D0 (en) | Concept fifteen | |
| ZA200508325B (en) | Manufacture of kerbstones | |
| GB0421059D0 (en) | Concept thirteen | |
| GB0412138D0 (en) | Definition of zeroclick | |
| HU0400952D0 (en) | Treatment of anus-cancer | |
| GB0426033D0 (en) | Priority pad |